RA
Ronak Agrawal
About Ronak Agrawal
Data last updated:
Ronak Agrawal is a Director at Aries Drugs Private Limited (since 2024) and Director at Gemcross Formulation Private Limited (since 2026). The companies operate in Healthcare. The largest current company by reported revenue is Aries Drugs Private Limited at ₹2.58 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 May 2024 | 2005 | ₹2.58 Cr (FY 2024) | Active | |
| Director | 13 Jul 2026 | 2026 | Active |
Board colleagues of Ronak Agrawal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Agarwal | 00660463 | Aries Drugs Private Limited | Managing Director |
| Hari Om Agarwal | 00660604 | Aries Drugs Private Limited | Director |
| Madan Lal Agarwal | 08350695 | Aries Drugs Private Limited , Gemcross Formulation Private Limited | Director |
| Chitra Agrawal | 08350694 | Gemcross Formulation Private Limited | Individual Subscriber |
| Mayank Agrawal | Gemcross Formulation Private Limited | Individual Subscriber |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ronak Agrawal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ronak Agrawal
Ronak Agrawal currently holds 2 directorships: Aries Drugs Private Limited (Director, since 02 May 2024, revenue ₹2.58 Cr (FY 2024)); Gemcross Formulation Private Limited (Director, since 13 Jul 2026).
Ronak Agrawal was first appointed on 02 May 2024 as Director at Aries Drugs Private Limited. The most recent appointment on record is 13 Jul 2026 at Gemcross Formulation Private Limited.
The current boards of Ronak Agrawal's companies include Amit Agarwal (Aries Drugs Private Limited), Hari Om Agarwal (Aries Drugs Private Limited), Madan Lal Agarwal (Aries Drugs Private Limited), Chitra Agrawal (Gemcross Formulation Private Limited), Mayank Agrawal (Gemcross Formulation Private Limited).